TCT 2023: Six-Month Clinical Data from DESyne® BDS Plus Randomized Controlled Trial (RCT) Support Safety and Effectiveness of World’s First Site-Specific Antithrombotic Drug Therapy
—The first RCT comparing use of site-specific antithrombotic drug therapy with two anticoagulants and an anti-proliferative mTOR inhibitor versus traditional drug-eluting... Read more.
KBRA Releases ABS East 2023 Conference: Day 2 Recap
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases a Day 2 recap of the ABS East 2023 conference held at the Fontainebleau in Miami on October 23-25.... Read more.
Cadence Expands Pfizer’s License to Molecular Design Software
Includes access to computational software designed to help advance innovation in traditional and AI-based drug discovery SAN JOSE, Calif.–(BUSINESS WIRE)–Cadence... Read more.
Pearl Street Equity Acquires Famous Brands Franchising Business, Parent Company of Iconic Brands Mrs. Fields® and TCBY®
Business to Pursue Expansion Opportunities in Both Domestic and International Markets NEW YORK–(BUSINESS WIRE)–Pearl Street Equity LLC (or “Pearl Street”)... Read more.
FTCH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Farfetch Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Farfetch Limited (NYSE: FTCH)... Read more.
Focal Medical Complete Development of a Therapeutic System to Deliver Gemcitabine Directly to the Pancreas
Successful completion of development of a precision therapeutic system designed to safely achieve high concentration of chemotherapeutic in target organ, via non-circulatory... Read more.
NIPSCO Seeks Natural Gas Rate Adjustment to Support System Modernization and Upgrades Driven by Federal Safety and Compliance Requirements
Plan supports: Infrastructure modernization Economic development and job creation-related projects System improvements that directly benefit customers and communities... Read more.
Rising Demand for Fluorescent in Situ Hybridization (FISH) Probes in Clinical Procedures and Cancer Diagnostics Drives Market Expansion Despite Pathologist Shortages – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Fluorescent in Situ Hybridization (FISH) Probe Market: (by Product, Technology, End User, Application, &... Read more.
Establishment Labs to Announce Third Quarter 2023 Financial Results on November 7
NEW YORK–(BUSINESS WIRE)–Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health... Read more.
Textron Declares Quarterly Dividend
PROVIDENCE, R.I.–(BUSINESS WIRE)–The Board of Directors of Textron Inc. (NYSE:TXT) today declared a quarterly dividend of $0.02 per share on the company’s... Read more.